433 related articles for article (PubMed ID: 24618636)
1. Knowledge and awareness of HPV vaccine and acceptability to vaccinate in sub-Saharan Africa: a systematic review.
Perlman S; Wamai RG; Bain PA; Welty T; Welty E; Ogembo JG
PLoS One; 2014; 9(3):e90912. PubMed ID: 24618636
[TBL] [Abstract][Full Text] [Related]
2. Model-based impact and cost-effectiveness of cervical cancer prevention in sub-Saharan Africa.
Kim JJ; Campos NG; O'Shea M; Diaz M; Mutyaba I
Vaccine; 2013 Dec; 31 Suppl 5():F60-72. PubMed ID: 24331749
[TBL] [Abstract][Full Text] [Related]
3. Infrastructure requirements for human papillomavirus vaccination and cervical cancer screening in sub-Saharan Africa.
Sankaranarayanan R; Anorlu R; Sangwa-Lugoma G; Denny LA
Vaccine; 2013 Dec; 31 Suppl 5():F47-52. PubMed ID: 24331747
[TBL] [Abstract][Full Text] [Related]
4. Appraisal of willingness to vaccinate daughters with human papilloma virus vaccine and cervical cancer screening uptake among mothers of adolescent students in Abakaliki, Nigeria.
Azuogu BN; Umeokonkwo CD; Azuogu VC; Onwe OE; Okedo-Alex IN; Egbuji CC
Niger J Clin Pract; 2019 Sep; 22(9):1286-1291. PubMed ID: 31489868
[TBL] [Abstract][Full Text] [Related]
5. HPV vaccine acceptability in Africa: a systematic review.
Cunningham MS; Davison C; Aronson KJ
Prev Med; 2014 Dec; 69():274-9. PubMed ID: 25451327
[TBL] [Abstract][Full Text] [Related]
6. Adolescents' awareness of HPV infections and attitudes towards HPV vaccination 3 years following the introduction of the HPV vaccine in Hungary.
Marek E; Dergez T; Rebek-Nagy G; Kricskovics A; Kovacs K; Bozsa S; Kiss I; Ember I; Gocze P
Vaccine; 2011 Nov; 29(47):8591-8. PubMed ID: 21939711
[TBL] [Abstract][Full Text] [Related]
7. Adolescent Health Series: HPV infection and vaccination in sub-Saharan Africa: 10 years of research in Tanzanian female adolescents - narrative review.
Whitworth H; Changalucha J; Baisley K; Watson-Jones D
Trop Med Int Health; 2021 Nov; 26(11):1345-1355. PubMed ID: 34310816
[TBL] [Abstract][Full Text] [Related]
8. A case study using the United Republic of Tanzania: costing nationwide HPV vaccine delivery using the WHO Cervical Cancer Prevention and Control Costing Tool.
Hutubessy R; Levin A; Wang S; Morgan W; Ally M; John T; Broutet N
BMC Med; 2012 Nov; 10():136. PubMed ID: 23146319
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus and cervical cancer risk perception and vaccine acceptability among adolescent girls and young women in Durban, South Africa.
Russell VL; Ogilvie G; Beksinska M; Nyrenda M; Mitchell-Foster S; Lavoie J; Harder H; Wood B; Smith P; Dietrich JJ; Smit J; Brockman MA; Gray G; Kaida On Behalf Of The Ayazazi Research Team A
S Afr Med J; 2020 Aug; 110(9):887-893. PubMed ID: 32880274
[TBL] [Abstract][Full Text] [Related]
10. Implementation of human papillomavirus immunization in the developing world.
Kane MA; Serrano B; de Sanjosé S; Wittet S
Vaccine; 2012 Nov; 30 Suppl 5():F192-200. PubMed ID: 23199963
[TBL] [Abstract][Full Text] [Related]
11. Parental acceptance of human papillomavirus (HPV) vaccination in Indonesia: a cross-sectional study.
Jaspers L; Budiningsih S; Wolterbeek R; Henderson FC; Peters AA
Vaccine; 2011 Oct; 29(44):7785-93. PubMed ID: 21821079
[TBL] [Abstract][Full Text] [Related]
12. Cervical cancer and HPV: Awareness and vaccine acceptability among parents in Morocco.
Mouallif M; Bowyer HL; Festali S; Albert A; Filali-Zegzouti Y; Guenin S; Delvenne P; Waller J; Ennaji MM
Vaccine; 2014 Jan; 32(3):409-16. PubMed ID: 24188754
[TBL] [Abstract][Full Text] [Related]
13. Improvement of Parent's awareness, knowledge, perception, and acceptability of human papillomavirus vaccination after a structured-educational intervention.
Sitaresmi MN; Rozanti NM; Simangunsong LB; Wahab A
BMC Public Health; 2020 Dec; 20(1):1836. PubMed ID: 33256697
[TBL] [Abstract][Full Text] [Related]
14. Central American Immigrant Parents' Awareness, Acceptability, and Willingness to Vaccinate Their Adolescent Children Against Human Papillomavirus: A Pilot Cross-Sectional Study.
Lindsay AC; Pineda JA; Valdez MJ; Torres MI; Granberry PJ
Int J Environ Res Public Health; 2020 Apr; 17(8):. PubMed ID: 32326320
[TBL] [Abstract][Full Text] [Related]
15. Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries.
Goldie SJ; O'Shea M; Campos NG; Diaz M; Sweet S; Kim SY
Vaccine; 2008 Jul; 26(32):4080-93. PubMed ID: 18550229
[TBL] [Abstract][Full Text] [Related]
16. A qualitative analysis of South African women's knowledge, attitudes, and beliefs about HPV and cervical cancer prevention, vaccine awareness and acceptance, and maternal-child communication about sexual health.
Francis SA; Battle-Fisher M; Liverpool J; Hipple L; Mosavel M; Soogun S; Mofammere N
Vaccine; 2011 Nov; 29(47):8760-5. PubMed ID: 21855591
[TBL] [Abstract][Full Text] [Related]
17. Awareness of cervical cancer and willingness to be vaccinated against human papillomavirus in Mozambican adolescent girls.
Bardají A; Mindu C; Augusto OJ; Casellas A; Cambaco O; Simbine E; Matsinhe G; Macete E; Menéndez C; Sevene E; Munguambe K
Papillomavirus Res; 2018 Jun; 5():156-162. PubMed ID: 29665430
[TBL] [Abstract][Full Text] [Related]
18. Determinants of acceptance and subsequent uptake of the HPV vaccine in a cohort in Eldoret, Kenya.
Vermandere H; Naanyu V; Mabeya H; Vanden Broeck D; Michielsen K; Degomme O
PLoS One; 2014; 9(10):e109353. PubMed ID: 25299646
[TBL] [Abstract][Full Text] [Related]
19. Costs of introducing and delivering HPV vaccines in low and lower middle income countries: inputs for GAVI policy on introduction grant support to countries.
Levin A; Wang SA; Levin C; Tsu V; Hutubessy R
PLoS One; 2014; 9(6):e101114. PubMed ID: 24968002
[TBL] [Abstract][Full Text] [Related]
20. Human Papillomavirus Vaccine Acceptability among Parents of Adolescent Girls in a Rural Area, Mysore, India.
Degarege A; Krupp K; Fennie K; Srinivas V; Li T; Stephens DP; Marlow LAV; Arun A; Madhivanan P
J Pediatr Adolesc Gynecol; 2018 Dec; 31(6):583-591. PubMed ID: 30055285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
